Maximizing the Impact of Microphysiological Systems with in Vitro–in Vivo Translation
Author(s)
Stokes, Cynthia L.; Cirit, Murat
Downloadc8lc00039e.pdf (889.9Kb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Microphysiological systems (MPS) hold promise for improving therapeutic drug approval rates by providing more physiological, human-based, in vitro assays for preclinical drug development activities compared to traditional in vitro and animal models. Here, we first summarize why MPSs are needed in pharmaceutical development, and examine how MPS technologies can be utilized to improve preclinical efforts. We then provide the perspective that the full impact of MPS technologies will be realized only when robust approaches for in vitro-in vivo (MPS-to-human) translation are developed and utilized, and explain how the burgeoning field of quantitative systems pharmacology (QSP) can fill that need.
Date issued
2018-06Department
Massachusetts Institute of Technology. Department of Biological EngineeringJournal
Lab on a Chip
Publisher
Royal Society of Chemistry (RSC)
Citation
Cirit, Murat, and Cynthia L. Stokes. “Maximizing the Impact of Microphysiological Systems with in Vitro–in Vivo Translation.” Lab on a Chip 18, 13 (2018): 1831–1837 © 2018 Royal Society of Chemistry
Version: Final published version
ISSN
1473-0197
1473-0189